Trial intelligence / Profile preview

Metformin and Glycolic Acid in Acanthosis Nigricans

NCT07751549Completed

Sponsor
Tanta University
Start
Jun 2023
Primary completion
Jul 2025
Countries
1
01

Overview

Randomised, single-blind trial of metformin 1% gel in acanthosis nigricans (3 arms), sponsored by Tanta University. Primary endpoint: Acanthosis Nigricans Area and Severity Index at 3 months. Started Jun 2023; status: completed.

02

Drugs

metformin 1% gel
03

Conditions

acanthosis nigricans

Beyond the preview

Go deeper on NCT07751549.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07751549.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call